Author： Frishman Dmitrij Kaps Andreas Mewes Hans-Werner
Publisher： Future Medicine
ISSN： 1462-2416
Source： Pharmacogenomics, Vol.3, Iss.2, 2002-03, pp. : 265-271
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Antidepressants for the new millennium
By Skolnick P.
European Journal of Pharmacology, Vol. 375, Iss. 1, 1999-06 ,pp. :
Access to resources
Recommend
Genomics and new targets for multiple sclerosis
By Baranzini Sergio E Oksenberg Jorge R
Pharmacogenomics, Vol. 6, Iss. 2, 2005-03 ,pp. :
Microbial genomics – new targets, new drugs
Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 4, 2001-08 ,pp. :
Safety of Inhaled and Intranasal Corticosteroids: Lessons for the New Millennium
Drug Safety, Vol. 23, Iss. 1, 2000-07 ,pp. :